The human fetal glial cell line SVG p12 contains infectious BK polyomavirus

Journal of Virology

Volumn 88, Issue 13, 2014, Pages 7556-7568

  Henriksen, Stian ^a   Tylden, Garth D ^a,b   Dumoulin, Alexis ^c,e   Sharma, Biswa Nath ^a,b   Hirsch, Hans H ^c,d   Rinaldo, Christine Hanssen ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e Valais Hospital   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; PROTEIN VP1; PROTEIN VP2; PROTEIN VP3; AGNOPROTEIN, POLYOMAVIRUS; VIRUS DNA; VIRUS PROTEIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BK VIRUS; CONTROLLED STUDY; CRYOPRESERVATION; DNA SEQUENCE; ELECTRON MICROSCOPY; ENZYME SPECIFICITY; GENE REPLICATION; GENE SEQUENCE; GLIA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RADIOIMMUNOPRECIPITATION; TRANSMISSION ELECTRON MICROSCOPY; VIRUS LOAD; VIRUS REPLICATION; WESTERN BLOTTING; CELL CULTURE; CYTOLOGY; FETUS; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; GLIA; HIGH THROUGHPUT SEQUENCING; JC VIRUS; METABOLISM; PHYSIOLOGY; POLYOMAVIRUS INFECTION; REAL TIME POLYMERASE CHAIN REACTION; VIROLOGY; VIRUS INFECTION;

BK VIRUS; BLOTTING, WESTERN; CELLS, CULTURED; DNA, VIRAL; FETUS; FLUORESCENT ANTIBODY TECHNIQUE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; JC VIRUS; NEUROGLIA; POLYOMAVIRUS INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR VIRUS INFECTIONS; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRUS REPLICATION;

EID: 84901992637     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00696-14     Document Type: Article

References (78)

1. Rinaldo CH, Hirsch HH. 2013. The human polyomaviruses: from orphans and mutants to patchwork family. APMIS 121:681-684. http://dx .doi.org/10.1111/apm.12125.
2. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH. 1971. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet i:1257-1260.
3. Gardner SD, Field AM, Coleman DV, Hulme B. 1971. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet i:1253-1257.
4. Chesters PM, Heritage J, McCance DJ. 1983. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J. Infect. Dis. 147:676-684. http://dx.doi.org/10.1093/infdis/147 .4.676.
5. Egli A, Infanti L, Dumoulin A, Buser A, Samaridis J, Stebler C, Gosert R, Hirsch HH. 2009. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J. Infect. Dis. 199:837-846. http: //dx.doi.org/10.1086/597126.
6. Hirsch HH, Kardas P, Kranz D, Leboeuf C. 2013. The human JC polyomavirus (JCPyV): virological background and clinical implications. APMIS 121:685-727. http://dx.doi.org/10.1111/apm.12128.
7. Rinaldo CH, Tylden GD, Sharma BN. 2013. The human polyomavirus BK (BKPyV): virological background and clinical implications. APMIS 121:728-745. http://dx.doi.org/10.1111/apm.12134.
8. Cole CN. 1996. Polyomavirinae: the viruses and their replication, p 1997-2025. In Fields BN, Knipe DM, Howley PM (ed), Fields virology, 3rd ed. Lippincott-Raven, Philadelphia, PA.
9. Trowbridge PW, Frisque RJ. 1995. Identification of three new JC virus proteins generated by alternative splicing of the early viral mRNA. J. Neurovirol. 1:195-206. http://dx.doi.org/10.3109/13550289509113966.
10. Abend JR, Joseph AE, Das D, Campbell-Cecen DB, Imperiale MJ. 2009. A truncated T antigen expressed from an alternatively spliced BK virus early mRNA. J. Gen. Virol. 90:1238-1245. http://dx.doi.org/10.1099/vir.0 .009159-0.
11. An P, Saenz Robles MT, Pipas JM. 2012. Large T antigens of polyomaviruses: amazing molecular machines. Annu. Rev. Microbiol. 66:213-236. http://dx.doi.org/10.1146/annurev-micro-092611-150154.
12. Ahuja D, Saenz-Robles MT, Pipas JM. 2005. SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 24: 7729-7745. http://dx.doi.org/10.1038/sj.onc.1209046.
13. Tan CS, Broge TA, Jr, Seung E, Vrbanac V, Viscidi R, Gordon J, Tager AM, Koralnik IJ. 2013. Detection of JC virus-specific immune responses in a novel humanized mouse model. PLoS One 8:e64313. http://dx.doi.org /10.1371/journal.pone.0064313.
14. Hirsch HH. 2010. Polyoma and papilloma virus infections after hematopoietic stem cell or solid organ transplantation, p 465-482. In Bowden P, Ljungman P, Snydman DR (ed), Transplant infections, 3rd ed. Lippincott Williams & Wilkins, Philadelphia, PA.
15. Low J, Humes HD, Szczypka M, Imperiale M. 2004. BKV and SV40 infection of human kidney tubular epithelial cells in vitro. Virology 323: 182-188. http://dx.doi.org/10.1016/j.virol.2004.03.027.
16. Bernhoff E, Gutteberg TJ, Sandvik K, Hirsch HH, Rinaldo CH. 2008. Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression. Am. J. Transplant. 8:1413-1422. http://dx.doi.org/10.1111/j.1600-6143.2008.02269.x.
17. Li R, Sharma BN, Linder S, Gutteberg TJ, Hirsch HH, Rinaldo CH.2013. Characteristics of polyomavirus BK (BKPyV) infection in primary human urothelial cells. Virology 440:41-50. http://dx.doi.org/10.1016/j .virol.2013.01.024.
18. Mesquita R, Bjorkholm M, Ekman M, Bogdanovic G, Biberfeld P. 1996. Polyomavirus-infected oligodendrocytes and macrophages within astrocytes in progressive multifocal leukoencephalopathy (PML). APMIS 104: 153-160. http://dx.doi.org/10.1111/j.1699-0463.1996.tb00701.x.
19. Broekema NM, Imperiale MJ. 2012. Efficient propagation of archetype BK and JC polyomaviruses. Virology 422:235-241. http://dx.doi.org/10 .1016/j.virol.2011.10.026.
20. Shaw G, Morse S, Ararat M, Graham FL. 2002. Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J. 16:869-871.
21. Major EO, Miller AE, Mourrain P, Traub RG, de Widt E, Sever J. 1985. Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc. Natl. Acad. Sci. U. S. A. 82:1257-1261. http://dx.doi .org/10.1073/pnas.82.4.1257.
22. Gluzman Y, Sambrook JF, Frisque RJ. 1980. Expression of early genes of origin-defective mutants of simian virus 40. Proc. Natl. Acad. Sci. U. S. A. 77:3898-3902. http://dx.doi.org/10.1073/pnas.77.7.3898.
23. Dowling-Warriner CV, Trosko JE. 2000. Induction of gap junctional intercellular communication, connexin43 expression, and subsequent differentiation in human fetal neuronal cells by stimulation of the cyclic AMP pathway. Neuroscience 95:859-868.
24. Heron PM, Turchan-Cholewo J, Bruce-Keller AJ, Wilson ME. 2009. Estrogen receptor alpha inhibits the estrogen-mediated suppression of HIV transcription in astrocytes: implications for estrogen neuroprotection in HIV dementia. AIDS Res. Hum. Retroviruses 25:1071-1081. http: //dx.doi.org/10.1089/aid.2009.0065.
25. Fuente-Martin E, Garcia-Caceres C, Morselli E, Clegg DJ, Chowen JA, Finan B, Brinton RD, Tschop MH. 2013. Estrogen, astrocytes and the neuroendocrine control of metabolism. Rev. Endocr. Metab. Disord. 14: 331-338. http://dx.doi.org/10.1007/s11154-013-9263-7.
26. Frye S, Trebst C, Dittmer U, Petry H, Bodemer M, Hunsmann G, Weber T, Luke W. 1997. Efficient production of JC virus in SVG cells and the use of purified viral antigens for analysis of specific humoral and cellular immune response. J. Virol. Methods 63:81-92. http://dx.doi.org/10 .1016/S0166-0934(96)02117-9.
27. Jiang ZG, Cohen J, Marshall LJ, Major EO. 2010. Hexadecyloxypropylcidofovir (CMX001) suppresses JC virus replication in human fetal brain SVG cell cultures. Antimicrob. Agents Chemother. 54:4723-4732. http: //dx.doi.org/10.1128/AAC.00837-10.
28. Bofill-Mas S, Clemente-Casares P, Major EO, Curfman B, Girones R.2003. Analysis of the excreted JC virus strains and their potential oral transmission. J. Neurovirol. 9:498-507. http://dx.doi.org/10.1080 /13550280390218887.
29. Brickelmaier M, Lugovskoy A, Kartikeyan R, Reviriego-Mendoza MM, Allaire N, Simon K, Frisque RJ, Gorelik L. 2009. Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob. Agents Chemother. 53:1840-1849. http://dx.doi.org/10.1128/AAC .01614-08.
30. Sariyer IK, Saribas AS, White MK, Safak M. 2011. Infection by agnoprotein-negative mutants of polyomavirus JC and SV40 results in the release of virions that are mostly deficient in DNA content. Virol. J. 8:255. http://dx.doi.org/10.1186/1743-422X-8-255.
31. Gasparovic ML, Maginnis MS, O'Hara BA, Dugan AS, Atwood WJ.2009. Modulation of PML protein expression regulates JCV infection. Virology 390:279-288. http://dx.doi.org/10.1016/j.virol.2009.05.017.
32. Dang X, Vidal JE, Oliveira AC, Simpson DM, Morgello S, Hecht JH, Ngo LH, Koralnik IJ. 2012. JC virus granule cell neuronopathy is associated with VP1 C terminus mutants. J. Gen. Virol. 93:175-183. http://dx .doi.org/10.1099/vir.0.037440-0.
33. Nelson CD, Derdowski A, Maginnis MS, O'Hara BA, Atwood WJ. 2012. The VP1 subunit of JC polyomavirus recapitulates early events in viral trafficking and is a novel tool to study polyomavirus entry. Virology 428: 30-40. http://dx.doi.org/10.1016/j.virol.2012.03.014.
34. Ferenczy MW, Johnson KR, Steinberg SM, Marshall LJ, Monaco MC, Beschloss AM, Jensen PN, Major EO. 2013. Clonal immortalized human glial cell lines support varying levels of JC virus infection due to differences in cellular gene expression. J. Neuroimmune Pharmacol. 8:1303-1319. http://dx.doi.org/10.1007/s11481-013-9499-8.
35. Goldmann C, Petry H, Frye S, Ast O, Ebitsch S, Jentsch KD, Kaup FJ, Weber F, Trebst C, Nisslein T, Hunsmann G, Weber T, Luke W. 1999. Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: formation of virus-like particles useful for immunological and therapeutic studies. J. Virol. 73:4465-4469.
36. Hou J, Major EO. 1998. The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line. J. Neurovirol. 4:451-456. http://dx.doi.org/10.3109/13550289809114545.
37. Qu Q, Sawa H, Suzuki T, Semba S, Henmi C, Okada Y, Tsuda M, Tanaka S, Atwood WJ, Nagashima K. 2004. Nuclear entry mechanism of the human polyomavirus JC virus-like particle: role of importins and the nuclear pore complex. J. Biol. Chem. 279:27735-27742.
38. Orba Y, Suzuki T, Makino Y, Kubota K, Tanaka S, Kimura T, Sawa H.2010. Large T antigen promotes JC virus replication in G2-arrested cells by inducing ATM-and ATR-mediated G2 checkpoint signaling. J. Biol. Chem. 285:1544-1554. http://dx.doi.org/10.1074/jbc.M109.064311.
39. Wang M, Tsou TH, Chen LS, Ou WC, Chen PL, Chang CF, Fung CY, Chang D. 2004. Inhibition of simian virus 40 large tumor antigen expression in human fetal glial cells by an antisense oligodeoxynucleotide delivered by the JC virus-like particle. Hum. Gene Ther. 15:1077-1090. http: //dx.doi.org/10.1089/hum.2004.15.1077.
40. Pho MT, Ashok A, Atwood WJ. 2000. JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis. J. Virol. 74:2288-2292. http://dx.doi.org/10.1128/JVI.74.5.2288-2292.2000.
41. Zins SR, Nelson CD, Maginnis MS, Banerjee R, O'Hara BA, Atwood WJ.2014. The human alpha defensin HD5 neutralizes JC polyomavirus infection by reducing endoplasmic reticulum traffic and stabilizing the viral capsid. J. Virol. 88:948-960. http://dx.doi.org/10.1128/JVI.02766-13.
42. Schweighardt B, Shieh JT, Atwood WJ. 2001. CD4/CXCR4-independent infection of human astrocytes by a T-tropic strain of HIV-1. J. Neurovirol. 7:155-162. http://dx.doi.org/10.1080/13550280152058816.
43. Rinaldo CH, Gosert R, Bernhoff E, Finstad S, Hirsch HH. 2010. 1-Ohexadecyloxypropyl cidofovir (CMX001) effectively inhibits polyomavirus BK replication in primary human renal tubular epithelial cells. Antimicrob. Agents Chemother. 54:4714-4722. http://dx.doi.org/10.1128 /AAC.00974-10.
44. Hey AW, Johnsen JI, Johansen B, Traavik T. 1994. A two fusion partner system for raising antibodies against small immunogens expressed in bacteria. J. Immunol. Methods 173:149-156. http://dx.doi.org/10.1016/0022-1759(94)90294-1.
45. Rinaldo CH, Traavik T, Hey A. 1998. The agnogene of the human polyomavirus BK is expressed. J. Virol. 72:6233-6236.
46. Rinaldo CH, Myhre MR, Alstad H, Nilssen O, Traavik T. 2003. Human polyomavirus BK (BKV) transiently transforms and persistently infects cultured osteosarcoma cells. Virus Res. 93:181-187. http://dx.doi.org/10 .1016/S0168-1702(03)00096-0.
47. Dumoulin A, Hirsch HH. 2011. Reevaluating and optimizing polyomavirus BK and JC real-time PCR assays to detect rare sequence polymorphisms. J. Clin. Microbiol. 49:1382-1388. http://dx.doi.org/10.1128/JCM .02008-10.
48. Agostini HT, Stoner GL. 1995. Amplification of the complete polyomavirus JC genome from brain, cerebrospinal fluid and urine using pre-PCR restriction enzyme digestion. J. Neurovirol. 1:316-320. http://dx.doi.org /10.3109/13550289509114028.
49. Olsen GH, Hirsch HH, Rinaldo CH. 2009. Functional analysis of polyomavirus BK non-coding control region quasispecies from kidney transplant recipients. J. Med. Virol. 81:1959-1967. http://dx.doi.org/10.1002 /jmv.21605.
50. Sundsfjord A, Johansen T, Flaegstad T, Moens U, Villand P, Subramani S, Traavik T. 1990. At least two types of control regions can be found among naturally occurring BK virus strains. J. Virol. 64:3864-3871.
51. Sharma PM, Gupta G, Vats A, Shapiro R, Randhawa P. 2006. Phylogenetic analysis of polyomavirusBKsequences. J. Virol. 80:8869-8879. http: //dx.doi.org/10.1128/JVI.00510-06.
52. Gee GV, Manley K, Atwood WJ. 2003. Derivation of a JC virus-resistant human glial cell line: implications for the identification of host cell factors that determine viral tropism. Virology 314:101-109. http://dx.doi.org/10 .1016/S0042-6822(03)00389-1.
53. Orba Y, Sawa H, Iwata H, Tanaka S, Nagashima K. 2004. Inhibition of virus production in JC virus-infected cells by postinfection RNA interference. J. Virol. 78:7270-7273. http://dx.doi.org/10.1128/JVI.78.13.7270-7273.2004.
54. Ashok A, Atwood WJ. 2003. Contrasting roles of endosomal pH and the cytoskeleton in infection of human glial cells by JC virus and simian virus40. J. Virol. 77:1347-1356. http://dx.doi.org/10.1128/JVI.77.2.1347-1356 .2003.
55. Querbes W, Benmerah A, Tosoni D, Di Fiore PP, Atwood WJ. 2004. A JC virus-induced signal is required for infection of glial cells by a clathrinand eps15-dependent pathway. J. Virol. 78:250-256. http://dx.doi.org/10 .1128/JVI.78.1.250-256.2004.
56. Schweighardt B, Atwood WJ. 2001. HIV type 1 infection of human astrocytes is restricted by inefficient viral entry. AIDS Res. Hum. Retroviruses 17:1133-1142. http://dx.doi.org/10.1089/088922201316912745.
57. Unterstab G, Gosert R, Leuenberger D, Lorentz P, Rinaldo CH, Hirsch HH. 2010. The polyomavirus BK agnoprotein co-localizes with lipid droplets. Virology 399:322-331. http://dx.doi.org/10.1016/j.virol.2010.01 .011.
58. Vandenbroucke I, Van Marck H, Verhasselt P, Thys K, Mostmans W, Dumont S, Van Eygen V, Coen K, Tuefferd M, Aerssens J. 2011. Minor variant detection in amplicons using 454 massive parallel pyrosequencing: experiences and considerations for successful applications. Biotechniques 51:167-177.
59. Wang Y, Lee OO, Yang JK, Li TG, Qian PY. 2013. Artifactual pyrosequencing reads in multiple-displacement-amplified sediment metagenomes from the Red Sea. PeerJ 1:e69. http://dx.doi.org/10.7717/peerj.69.
60. Myhre MR, Olsen GH, Gosert R, Hirsch HH, Rinaldo CH. 2010. Clinical polyomavirus BK variants with agnogene deletion are nonfunctional but rescued by trans-complementation. Virology 398:12-20. http://dx.doi.org/10.1016/j.virol.2009.11.029.
61. Yoshiike K, Miyamura T, Chan HW, Takemoto KK. 1982. Two defective DNAsof human polyomavirus JC adapted to growth in human embryonic kidney cells. J. Virol. 42:395-401.
62. Mandl C, Walker DL, Frisque RJ. 1987. Derivation and characterization of POJ cells, transformed human fetal glial cells that retain their permissivity for JC virus. J. Virol. 61:755-763.
63. Hu L, Filippakis H, Huang H, Yen TJ, Gjoerup OV. 2013. Replication stress and mitotic dysfunction in cells expressing simian virus 40 large T antigen. J. Virol. 87:13179-13192. http://dx.doi.org/10.1128/JVI.02224-13.
64. O'Neill FJ, Carroll D. 1983. Role of defective simian virus 40 genomes in establishment and maintenance of persistently infected primate cell lines. Intervirology 19:181-194.
65. Martin JD, Padgett BL, Walker DL. 1983. Characterization of tissue culture-induced heterogeneity in DNAs of independent isolates of JC virus. J. Gen. Virol. 64(Part 10):2271-2280. http://dx.doi.org/10.1099/0022-1317-64-10-2271.
66. Jorgensen GE, Hammarin AL, Bratt G, Grandien M, Flaegstad T, Johnsen JI. 2003. Identification of a unique BK virus variant in the CNS of a patient with AIDS. J. Med. Virol. 70:14-19. http://dx.doi.org/10.1002 /jmv.10370.
67. Barcena-Panero A, Echevarria JE, Van Ghelue M, Fedele G, Royuela E, Gerits N, Moens U. 2012. BK polyomavirus with archetypal and rearranged non-coding control regions is present in cerebrospinal fluids from patients with neurological complications. J. Gen. Virol. 93:1780-1794. http://dx.doi.org/10.1099/vir.0.042143-0.
68. Vidal JE, Fink MC, Cedeno-Laurent F, Delbue S, Ferrante P, Dauar RF, Filho FB, Nogueira RS, Calore EE, Pannuti CS, Trujillo JR, de Oliveira AC. 2007. BK virus associated meningoencephalitis in an AIDS patient treated with HAART. AIDS Res. Ther. 4:13. http://dx.doi.org/10.1186 /1742-6405-4-13.
69. Stoner GL, Alappan R, Jobes DV, Ryschkewitsch CF, Landry ML. 2002. BK virus regulatory region rearrangements in brain and cerebrospinal fluid from a leukemia patient with tubulointerstitial nephritis and meningoencephalitis. Am. J. Kidney Dis. 39:1102-1112. http://dx.doi.org/10 .1053/ajkd.2002.32795.
70. Elsner C, Dorries K. 1992. Evidence of human polyomavirus BK and JC infection in normal brain tissue. Virology 191:72-80. http://dx.doi.org/10 .1016/0042-6822(92)90167-N.
71. Boldorini R, Allegrini S, Miglio U, Nestasio I, Paganotti A, Veggiani C, Monga G, Pietropaolo V. 2010. BK virus sequences in specimens from aborted fetuses. J. Med. Virol. 82:2127-2132. http://dx.doi.org/10.1002 /jmv.21923.
72. Abend JR, Low JA, Imperiale MJ. 2007. Inhibitory effect of gamma interferon on BK virus gene expression and replication. J. Virol. 81:272-279. http://dx.doi.org/10.1128/JVI.01571-06.
73. Chen PL, Hsu PH, Fang CY, Chang CF, Ou WC, Wang M, Chang D.2011. Phosphorylation of Ser-80 of VP1 and Ser-254 of VP2 is essential for human BK virus propagation in tissue culture. J. Gen. Virol. 92:2637-2645. http://dx.doi.org/10.1099/vir.0.033282-0.
74. Fang CY, Chen HY, Wang M, Chen PL, Chang CF, Chen LS, Shen CH, Ou WC, Tsai MD, Hsu PH, Chang D. 2010. Global analysis of modifications of the humanBKvirus structural proteins by LC-MS/MS. Virology 402:164-176. http://dx.doi.org/10.1016/j.virol.2010.03.029.
75. Nesper J, Smith RW, Kautz AR, Sock E, Wegner M, Grummt F, Nasheuer HP. 1997. A cell-free replication system for human polyomavirus JC DNA. J. Virol. 71:7421-7428.
76. Rekvig OP, Bendiksen S, Moens U. 2006. Immunity and autoimmunity induced by polyomaviruses: clinical, experimental and theoretical aspects. Adv. Exp. Med. Biol. 577:117-147. http://dx.doi.org/10.1007/0-387-32957-9_9.
77. Chen Y, Sharp PM, Fowkes M, Kocher O, Joseph JT, Koralnik IJ. 2004. Analysis of 15 novel full-length BK virus sequences from three individuals: evidence of a high intra-strain genetic diversity. J. Gen. Virol. 85:2651-2663. http://dx.doi.org/10.1099/vir.0.79920-0.
78. Sundsfjord A, Spein AR, Lucht E, Flaegstad T, Seternes OM, Traavik T. 1994. Detection of BK virus DNA in nasopharyngeal aspirates from children with respiratory infections but not in saliva from immunodeficient and immunocompetent adult patients. J. Clin. Microbiol. 32: 1390-1394.